nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisapride—DRD2—Gilles de la Tourette syndrome	0.499	0.564	CbGaD
Cisapride—HTR2A—Gilles de la Tourette syndrome	0.386	0.436	CbGaD
Cisapride—HTR4—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00425	0.0482	CbGpPWpGaD
Cisapride—DRD2—Dopamine receptors—DRD3—Gilles de la Tourette syndrome	0.00377	0.0429	CbGpPWpGaD
Cisapride—DRD2—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.00366	0.0416	CbGpPWpGaD
Cisapride—HTR4—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0035	0.0398	CbGpPWpGaD
Cisapride—HTR4—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00299	0.0339	CbGpPWpGaD
Cisapride—HTR4—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0029	0.0329	CbGpPWpGaD
Cisapride—HTR4—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0027	0.0307	CbGpPWpGaD
Cisapride—HTR4—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00251	0.0285	CbGpPWpGaD
Cisapride—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00244	0.13	CbGeAlD
Cisapride—HTR4—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00244	0.0277	CbGpPWpGaD
Cisapride—HTR4—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00227	0.0258	CbGpPWpGaD
Cisapride—HTR4—brain—Gilles de la Tourette syndrome	0.00217	0.115	CbGeAlD
Cisapride—Iloperidone—DRD4—Gilles de la Tourette syndrome	0.00202	0.229	CrCbGaD
Cisapride—HTR4—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00189	0.0215	CbGpPWpGaD
Cisapride—Iloperidone—DRD3—Gilles de la Tourette syndrome	0.00174	0.197	CrCbGaD
Cisapride—Metoclopramide—DRD3—Gilles de la Tourette syndrome	0.00172	0.196	CrCbGaD
Cisapride—HTR2B—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00167	0.0189	CbGpPWpGaD
Cisapride—HTR4—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00159	0.0181	CbGpPWpGaD
Cisapride—HTR2B—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00137	0.0156	CbGpPWpGaD
Cisapride—HTR2C—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00134	0.0153	CbGpPWpGaD
Cisapride—Iloperidone—DRD2—Gilles de la Tourette syndrome	0.0012	0.137	CrCbGaD
Cisapride—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.0012	0.0136	CbGpPWpGaD
Cisapride—Metoclopramide—DRD2—Gilles de la Tourette syndrome	0.00119	0.135	CrCbGaD
Cisapride—HTR2B—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00117	0.0133	CbGpPWpGaD
Cisapride—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.00116	0.0132	CbGpPWpGaD
Cisapride—HTR2B—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00114	0.0129	CbGpPWpGaD
Cisapride—HTR2C—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00111	0.0126	CbGpPWpGaD
Cisapride—HTR2B—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Gilles de la Tourette syndrome	0.00111	0.0126	CbGpPWpGaD
Cisapride—HTR2B—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00106	0.012	CbGpPWpGaD
Cisapride—HTR2B—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000985	0.0112	CbGpPWpGaD
Cisapride—DRD2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.000978	0.0111	CbGpPWpGaD
Cisapride—HTR2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.000962	0.0109	CbGpPWpGaD
Cisapride—HTR2B—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000956	0.0109	CbGpPWpGaD
Cisapride—HTR2C—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000945	0.0107	CbGpPWpGaD
Cisapride—Iloperidone—HTR2A—Gilles de la Tourette syndrome	0.00093	0.106	CrCbGaD
Cisapride—HTR2C—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000918	0.0104	CbGpPWpGaD
Cisapride—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Gilles de la Tourette syndrome	0.000894	0.0102	CbGpPWpGaD
Cisapride—HTR2B—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000891	0.0101	CbGpPWpGaD
Cisapride—HTR2C—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.000855	0.00971	CbGpPWpGaD
Cisapride—DRD2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000834	0.00947	CbGpPWpGaD
Cisapride—DRD2—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.00083	0.00943	CbGpPWpGaD
Cisapride—HTR2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000821	0.00932	CbGpPWpGaD
Cisapride—DRD2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00081	0.0092	CbGpPWpGaD
Cisapride—HTR2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000797	0.00905	CbGpPWpGaD
Cisapride—HTR2C—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000794	0.00902	CbGpPWpGaD
Cisapride—HTR2C—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000771	0.00876	CbGpPWpGaD
Cisapride—HTR3A—nervous system—Gilles de la Tourette syndrome	0.000766	0.0406	CbGeAlD
Cisapride—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000749	0.0397	CbGeAlD
Cisapride—HTR2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.000742	0.00843	CbGpPWpGaD
Cisapride—HTR2B—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000742	0.00843	CbGpPWpGaD
Cisapride—HTR3A—central nervous system—Gilles de la Tourette syndrome	0.000737	0.0391	CbGeAlD
Cisapride—HTR2C—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000718	0.00816	CbGpPWpGaD
Cisapride—DRD2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000701	0.00796	CbGpPWpGaD
Cisapride—HTR2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00069	0.00784	CbGpPWpGaD
Cisapride—DRD2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000681	0.00773	CbGpPWpGaD
Cisapride—HTR2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00067	0.00761	CbGpPWpGaD
Cisapride—HTR2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000624	0.00709	CbGpPWpGaD
Cisapride—HTR2B—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000624	0.00709	CbGpPWpGaD
Cisapride—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000616	0.0327	CbGeAlD
Cisapride—HTR2C—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000599	0.0068	CbGpPWpGaD
Cisapride—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000593	0.0315	CbGeAlD
Cisapride—HTR3A—brain—Gilles de la Tourette syndrome	0.000585	0.0311	CbGeAlD
Cisapride—HTR2B—nervous system—Gilles de la Tourette syndrome	0.000579	0.0307	CbGeAlD
Cisapride—HTR4—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000576	0.00654	CbGpPWpGaD
Cisapride—CYP2A6—brain—Gilles de la Tourette syndrome	0.000575	0.0305	CbGeAlD
Cisapride—DRD2—midbrain—Gilles de la Tourette syndrome	0.00057	0.0302	CbGeAlD
Cisapride—KCNH2—midbrain—Gilles de la Tourette syndrome	0.000562	0.0298	CbGeAlD
Cisapride—HTR4—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000559	0.00635	CbGpPWpGaD
Cisapride—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.000557	0.0296	CbGeAlD
Cisapride—DRD2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000528	0.006	CbGpPWpGaD
Cisapride—HTR4—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000521	0.00592	CbGpPWpGaD
Cisapride—HTR2C—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000503	0.00572	CbGpPWpGaD
Cisapride—HTR4—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000494	0.00561	CbGpPWpGaD
Cisapride—HTR4—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000479	0.00544	CbGpPWpGaD
Cisapride—HTR2C—brain—Gilles de la Tourette syndrome	0.000471	0.025	CbGeAlD
Cisapride—DRD2—nervous system—Gilles de la Tourette syndrome	0.000469	0.0249	CbGeAlD
Cisapride—KCNH2—nervous system—Gilles de la Tourette syndrome	0.000462	0.0245	CbGeAlD
Cisapride—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000451	0.0239	CbGeAlD
Cisapride—HTR4—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000446	0.00507	CbGpPWpGaD
Cisapride—KCNH2—central nervous system—Gilles de la Tourette syndrome	0.000445	0.0236	CbGeAlD
Cisapride—DRD2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000444	0.00504	CbGpPWpGaD
Cisapride—HTR2B—brain—Gilles de la Tourette syndrome	0.000442	0.0235	CbGeAlD
Cisapride—HTR3A—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000399	0.00454	CbGpPWpGaD
Cisapride—CYP2B6—nervous system—Gilles de la Tourette syndrome	0.000379	0.0201	CbGeAlD
Cisapride—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000376	0.0199	CbGeAlD
Cisapride—HTR4—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000376	0.00427	CbGpPWpGaD
Cisapride—HTR4—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000365	0.00414	CbGpPWpGaD
Cisapride—HTR4—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000365	0.00414	CbGpPWpGaD
Cisapride—CYP2B6—central nervous system—Gilles de la Tourette syndrome	0.000365	0.0193	CbGeAlD
Cisapride—HTR2A—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000365	0.00414	CbGpPWpGaD
Cisapride—DRD2—brain—Gilles de la Tourette syndrome	0.000358	0.019	CbGeAlD
Cisapride—HTR2A—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000354	0.00402	CbGpPWpGaD
Cisapride—KCNH2—brain—Gilles de la Tourette syndrome	0.000353	0.0187	CbGeAlD
Cisapride—HTR4—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00034	0.00386	CbGpPWpGaD
Cisapride—CYP2C8—brain—Gilles de la Tourette syndrome	0.000323	0.0171	CbGeAlD
Cisapride—HTR4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000313	0.00355	CbGpPWpGaD
Cisapride—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000309	0.0164	CbGeAlD
Cisapride—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000298	0.0158	CbGeAlD
Cisapride—CYP2B6—brain—Gilles de la Tourette syndrome	0.00029	0.0154	CbGeAlD
Cisapride—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000286	0.0152	CbGeAlD
Cisapride—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000282	0.0149	CbGeAlD
Cisapride—KCNH2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.000277	0.00314	CbGpPWpGaD
Cisapride—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000275	0.0146	CbGeAlD
Cisapride—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000271	0.0144	CbGeAlD
Cisapride—KCNH2—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	0.000253	0.00287	CbGpPWpGaD
Cisapride—CYP2A6—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.000243	0.00276	CbGpPWpGaD
Cisapride—HTR4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000238	0.0027	CbGpPWpGaD
Cisapride—HTR2A—brain—Gilles de la Tourette syndrome	0.000236	0.0125	CbGeAlD
Cisapride—HTR2B—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000226	0.00257	CbGpPWpGaD
Cisapride—HTR2B—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000219	0.00249	CbGpPWpGaD
Cisapride—CYP2D6—brain—Gilles de la Tourette syndrome	0.000215	0.0114	CbGeAlD
Cisapride—HTR4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000212	0.00241	CbGpPWpGaD
Cisapride—HTR4—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000206	0.00234	CbGpPWpGaD
Cisapride—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000204	0.00232	CbGpPWpGaD
Cisapride—DRD2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000197	0.00223	CbGpPWpGaD
Cisapride—HTR3A—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	0.000196	0.00223	CbGpPWpGaD
Cisapride—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000194	0.0022	CbGpPWpGaD
Cisapride—HTR4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000193	0.00219	CbGpPWpGaD
Cisapride—HTR4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000192	0.00218	CbGpPWpGaD
Cisapride—DRD2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000191	0.00217	CbGpPWpGaD
Cisapride—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000188	0.00214	CbGpPWpGaD
Cisapride—HTR4—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000187	0.00213	CbGpPWpGaD
Cisapride—HTR2B—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000185	0.0021	CbGpPWpGaD
Cisapride—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000182	0.00207	CbGpPWpGaD
Cisapride—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000177	0.00201	CbGpPWpGaD
Cisapride—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000175	0.00199	CbGpPWpGaD
Cisapride—HTR4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000174	0.00198	CbGpPWpGaD
Cisapride—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000173	0.00197	CbGpPWpGaD
Cisapride—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000168	0.00191	CbGpPWpGaD
Cisapride—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000166	0.00188	CbGpPWpGaD
Cisapride—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000165	0.00187	CbGpPWpGaD
Cisapride—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000161	0.00183	CbGpPWpGaD
Cisapride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000158	0.0018	CbGpPWpGaD
Cisapride—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000156	0.00178	CbGpPWpGaD
Cisapride—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000156	0.00178	CbGpPWpGaD
Cisapride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000154	0.00175	CbGpPWpGaD
Cisapride—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000152	0.00172	CbGpPWpGaD
Cisapride—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000149	0.0017	CbGpPWpGaD
Cisapride—HTR2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000148	0.00168	CbGpPWpGaD
Cisapride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000143	0.00163	CbGpPWpGaD
Cisapride—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000143	0.00163	CbGpPWpGaD
Cisapride—HTR2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000143	0.00163	CbGpPWpGaD
Cisapride—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000141	0.00161	CbGpPWpGaD
Cisapride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000138	0.00157	CbGpPWpGaD
Cisapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000136	0.00154	CbGpPWpGaD
Cisapride—HTR4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000135	0.00153	CbGpPWpGaD
Cisapride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000134	0.00152	CbGpPWpGaD
Cisapride—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000134	0.00152	CbGpPWpGaD
Cisapride—HTR2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000133	0.00152	CbGpPWpGaD
Cisapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000132	0.0015	CbGpPWpGaD
Cisapride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000123	0.00139	CbGpPWpGaD
Cisapride—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000123	0.00139	CbGpPWpGaD
Cisapride—HTR4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000122	0.00139	CbGpPWpGaD
Cisapride—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000119	0.00135	CbGpPWpGaD
Cisapride—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000116	0.00131	CbGpPWpGaD
Cisapride—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000116	0.00131	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—HDC—Gilles de la Tourette syndrome	0.000114	0.0013	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000114	0.00129	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000111	0.00126	CbGpPWpGaD
Cisapride—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000108	0.00122	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000105	0.00119	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000105	0.00119	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000103	0.00117	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000103	0.00117	CbGpPWpGaD
Cisapride—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000102	0.00116	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000102	0.00116	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0001	0.00114	CbGpPWpGaD
Cisapride—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	9.9e-05	0.00112	CbGpPWpGaD
Cisapride—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.35e-05	0.00106	CbGpPWpGaD
Cisapride—HTR2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.34e-05	0.00106	CbGpPWpGaD
Cisapride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.74e-05	0.000992	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—HDC—Gilles de la Tourette syndrome	8.45e-05	0.00096	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.34e-05	0.000947	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—HDC—Gilles de la Tourette syndrome	8.26e-05	0.000938	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.09e-05	0.000919	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.57e-05	0.00086	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.54e-05	0.000856	CbGpPWpGaD
Cisapride—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.54e-05	0.000856	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.35e-05	0.000835	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	7.22e-05	0.00082	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—HDC—Gilles de la Tourette syndrome	7.16e-05	0.000813	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.85e-05	0.000778	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.72e-05	0.000764	CbGpPWpGaD
Cisapride—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.65e-05	0.000756	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.53e-05	0.000742	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—HDC—Gilles de la Tourette syndrome	6.39e-05	0.000725	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	6.11e-05	0.000694	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	6.08e-05	0.000691	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.94e-05	0.000674	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.93e-05	0.000673	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	5.87e-05	0.000667	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.84e-05	0.000663	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	5.82e-05	0.000661	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.76e-05	0.000654	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.67e-05	0.000644	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.52e-05	0.000627	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.39e-05	0.000612	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.3e-05	0.000602	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.28e-05	0.0006	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.28e-05	0.0006	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.23e-05	0.000594	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.15e-05	0.000585	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	4.98e-05	0.000565	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.8e-05	0.000545	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.79e-05	0.000545	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.47e-05	0.000508	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.34e-05	0.000493	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.26e-05	0.000484	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.04e-05	0.000459	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.87e-05	0.000439	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	3.84e-05	0.000436	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.76e-05	0.000427	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.61e-05	0.00041	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.5e-05	0.000398	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.41e-05	0.000388	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.26e-05	0.000371	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.18e-05	0.000362	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.13e-05	0.000356	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.09e-05	0.000351	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.04e-05	0.000345	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.83e-05	0.000322	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.83e-05	0.000322	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.29e-05	0.00026	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.02e-05	0.000229	CbGpPWpGaD
